一个调节器介导的甲基化修饰模式与自相关,以预测肝细胞癌的预后
Yingmin Wu1,2,3,4, Lian Li5,6,7, Long Wang5,6,7
1Department of Physiology, School of Basic Medical Sciences, Guizhou Medical University, 561113, Guiyang, China. wuyingmin1990@126.com.
BMC cancer
|April 22, 2024
概括
在肝细胞癌 (HCC) 中,N1-甲基氨酸 (m1A) RNA的修改是至关重要的. 一个新的风险模型确定了m1A调节剂来预测HCC患者的预后,并建议针对癌症治疗的m1A.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- N1-甲基氨酸 (m1A) 是一种普遍存在的RNA修饰,与癌症发展有关.
- 了解肝细胞癌 (HCC) 的m1A特征对于确定新的治疗点至关重要.
研究的目的:
- 系统地调查HCC.A中的多种修饰模式.
- 开发基于m1A调节器的HCC患者预后预测模型.
- 探索m1A在HCC细胞生长和自中的作用.
主要方法:
- 对多个监管机构的TCGA-LIHC数据库的综合分析.
- 使用与m1A模式和自相关的差异表达基因 (DEGs) 构建风险模型.
- 在体外实验和免疫组织化学验证HCC组织中发现的结果.
主要成果:
- 一个五基因风险模型 (CDK5R2,TRIM36,DCAF8L,CYP26B,PAGE1) 证明了对HCC的显著预后价值.
- 与准癌性组织相比,HCC组织的m1A水平较低.
- 降低的m1A水平与较差的临床结果相关,并可能通过自抑制HCC扩散.
结论:
- 开发的风险模型,包括m1A调节器和自,可以预测HCC的预后.
- 降低的m1A水平是抗HCC策略的潜在治疗目标.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Histone Modification
13.3K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.3K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K


